// App-Quantinova.ai

5235 : In vitro validation of drug-target interactions revealed in silico by Comprehensive Resource of Biomedical Relations with Network Representations and Deep Learning (CROssBAR) in HCC

Researchers

Presenter

  • Esra Nalbat

Principal Investigators

  • Ahmet Sureyya Rifaioglu

  • Tunca Dogan

  • Maria Jesus Martin

  • Rengul Cetin-Atalay

  • Volkan Atalay

Medical Centers

  • Middle East Technical University (METU), Ankara, Turkey

  • Hacettepe University, Ankara, Turkey

  • European Bioinformatics Institute, Cambridge, United Kingdom

Locations

  • Turkey

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Annexin V

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • c-Jun N-terminal kinase

Drug/Treatment

  • Regorafenib

  • Lenvatinib

  • Sorafenib

  • Sunitinib

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved